UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1601
Werner Enterprises
WERN
$1.97B
| $2.93M | ﹤0.01% |
111,192
-118,561
| -52% | -$3.33M |
2013 Q2
49 quarters
|
|
1602
PureCycle Technologies
PCT
$617M
| $2.92M | ﹤0.01% |
221,946
-231,658
| -51% | -$3.22M |
2021 Q4
15 quarters
|
|
1603
DELISTED
Leggett & Platt
LEG
| $2.91M | ﹤0.01% |
327,839
-280,794
| -46% | -$2.68M |
2013 Q2
49 quarters
|
|
1604
Penguin Solutions Inc
PENG
$2.93B
| $2.91M | ﹤0.01% |
110,743
-69,762
| -39% | -$1.71M |
2020 Q4
19 quarters
|
|
1605
Integra LifeSciences
IART
$1.03B
| $2.91M | ﹤0.01% |
202,956
-105,183
| -34% | -$1.44M |
2013 Q2
49 quarters
|
|
1606
Dyne Therapeutics
DYN
$2.66B
| $2.9M | ﹤0.01% |
229,430
-64,214
| -22% | -$732K |
2021 Q3
16 quarters
|
|
1607
DELISTED
Verint Systems
VRNT
| $2.9M | ﹤0.01% |
143,300
-1,388,780
| -91% | -$28.6M |
2013 Q2
49 quarters
|
|
1608
LeMaitre Vascular
LMAT
$1.85B
| $2.89M | ﹤0.01% |
32,997
-23,372
| -41% | -$2.09M |
2018 Q1
30 quarters
|
|
1609
Lakeland Financial Corp
LKFN
$1.44B
| $2.87M | ﹤0.01% |
44,627
-26,928
| -38% | -$1.75M |
2017 Q2
33 quarters
|
|
1610
MillerKnoll
MLKN
$1.45B
| $2.86M | ﹤0.01% |
161,349
-108,610
| -40% | -$2.2M |
2013 Q2
49 quarters
|
|
1611
ACV Auctions
ACVA
$1.78B
| $2.86M | ﹤0.01% |
288,443
-184,877
| -39% | -$2.37M |
2021 Q1
18 quarters
|
|
1612
DELISTED
Dynavax Technologies
DVAX
| $2.85M | ﹤0.01% |
287,185
-205,540
| -42% | -$2.14M |
2015 Q2
41 quarters
|
|
1613
NextNav
NN
$1.62B
| $2.85M | ﹤0.01% |
199,350
-61,346
| -24% | -$968K |
2023 Q4
7 quarters
|
|
1614
Encore Capital Group
ECPG
$2.16B
| $2.84M | ﹤0.01% |
68,157
-33,448
| -33% | -$1.37M |
2017 Q1
34 quarters
|
|
1615
Albany International
AIN
$1.72B
| $2.84M | ﹤0.01% |
53,367
-35,622
| -40% | -$2.26M |
2023 Q1
10 quarters
|
|
1616
ACM Research
ACMR
$3.7B
| $2.84M | ﹤0.01% |
72,667
-469,070
| -87% | -$13.9M |
2020 Q1
22 quarters
|
|
1617
REX American Resources
REX
$1.38B
| $2.82M | ﹤0.01% |
91,970
-72,954
| -44% | -$2.08M |
2020 Q4
19 quarters
|
|
1618
DXP Enterprises
DXPE
$2.73B
| $2.81M | ﹤0.01% |
23,611
-17,780
| -43% | -$1.99M |
2020 Q3
20 quarters
|
|
1619
Barrick Mining
B
$67.2B
| $2.79M | ﹤0.01% |
85,193
-1,521,077
| -95% | -$38.5M |
2024 Q2
5 quarters
|
|
1620
Hilltop Holdings
HTH
$2.11B
| $2.79M | ﹤0.01% |
83,346
-60,182
| -42% | -$1.96M |
2013 Q2
49 quarters
|
|
1621
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$859M
| $2.78M | ﹤0.01% |
101,633
+21,503
| +27% | +$452K |
2025 Q2
1 quarter
|
|
1622
Circle Internet Group
CRCL
$20.9B
| $2.78M | ﹤0.01% |
20,965
+20,250
| +2,832% | +$3.2M |
2025 Q2
1 quarter
|
|
1623
Unitil
UTL
$986M
| $2.74M | ﹤0.01% |
57,164
-32,018
| -36% | -$1.56M |
2014 Q1
46 quarters
|
|
1624
Celldex Therapeutics
CLDX
$2.16B
| $2.73M | ﹤0.01% |
105,478
-108,368
| -51% | -$2.51M |
2020 Q4
19 quarters
|
|
1625
NeoGenomics
NEO
$2.14B
| $2.73M | ﹤0.01% |
353,258
-228,529
| -39% | -$1.6M |
2023 Q1
10 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.